Hovid Berhad (Symbol:HOVID) SWOT Analysis, Strategy, Revenues and Profits

• Publication date: November 2012
• Report size: 36 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hovid Berhad SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations. In this report, our analysts reveal the company’s busin...

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Hovid Berhad SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Hovid Berhad operations to identify potential customers, partners and suppliers. Hovid Berhad business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Generic Drug Industry in Malaysia

I - Hovid Berhad Company Profile

Key Information
Overview
Key Employees and biographies
Operational Heads
Main Products and Services
Historical Data
Company Mission Statement
Operations And Subsidiaries
Headquarter

II - Hovid Berhad Company Analysis

Business Description
Company Vision and Strategy
SWOT Analysis
Strengths, Weaknesses, Opportunities, Threats
Competitive Landscape

III - Hovid Berhad Financial Analysis and Performance Charts

Financial Ratios
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios

Generic Drug in Malaysia

Malaysia Generic Drug Sales, Us$bn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health Asia, domestic companies, local press, BMI

• Industries : Generic Drug
• Countries : Malaysia

Malaysia Generic Drug Sales, Us$bn

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: IMS Health Asia, domestic companies, local press, BMI

• Industries : Generic Drug
• Countries : Malaysia

Malaysia Generic Drug Sales, Myrbn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health Asia, domestic companies, local press, BMI

• Industries : Generic Drug
• Countries : Malaysia

Malaysia Generic Drug Sales, Myrbn

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: IMS Health Asia, domestic companies, local press, BMI

• Industries : Generic Drug
• Countries : Malaysia

Malaysia Generic Drug Sales, % Of Total Sales

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: IMS Health Asia, domestic companies, local press, BMI

• Industries : Generic Drug
• Countries : Malaysia